o
(866) 258-2735

Solutions

The iMednet eClinical platform offers a cost-effective solution with a full suite of native tools to simplify and shorten study build times, increase efficiency in study execution, and minimize costs through the duration of the study.

View All
Evolving Requirements for Trial Supply Management

Evolving Requirements for Trial Supply Management

Numerous factors are changing the way clinical trials are conducted. Increasingly complex trial designs, global patient groups, and decentralized trial models have significantly impacted how trial information is tracked and managed. These factors have also influenced...
Driving Innovation in Clinical Trials at SCOPE Summit 2022

Driving Innovation in Clinical Trials at SCOPE Summit 2022

SCOPE Summit 2022 in Orlando, FL is less than two weeks away, and the Mednet team is looking forward to exhibiting in person for the first time in two years! If you are attending in person, we hope you will stop by our booth for a bit of fun and to learn more about...
Looking Ahead to Clinical Trial Trends in 2022

Looking Ahead to Clinical Trial Trends in 2022

Saying hello to a new year has got us thinking about what’s in store for the clinical research industry in 2022. In the past two years, we have seen quick and substantial pivots in the way clinical trials are conducted. Every aspect of a trial has been reshaped,...
Why Adaptive Trial Designs Require Adaptable Technology

Why Adaptive Trial Designs Require Adaptable Technology

Adaptive trial designs emerged as a means to improve clinical trials based on all available information. High failure rates and increasing costs have driven the industry toward adaptive trial designs. In The Adaptive Designs for Clinical Trials of Drugs and Biologics...
What Does Real World Data Mean to Clinical Trial Teams?

What Does Real World Data Mean to Clinical Trial Teams?

Introduction  Real-Word Data (RWD) and Real-World Evidence (RWE) are acronyms that have been thrown around the industry for some time. As healthcare, life sciences companies and regulators look at the potential research opportunities that...